The enhancement of the antitumor effect of doxorubicin by TNFα, due to the suppression of the antiapoptotic activity of p21, was also confirmed by Jiang et al. [268], an in vivo bearing hepatoma H22 and sarcoma S180 allografted tumors [266]. Here, TNF is linked to hepatocellular carcinoma.